A Study to Evaluate the Efficacy and Safety of a Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seronegative Kidney Transplant Recipients Receiving an Organ From a CMV-Seropositive Donor
Public ClinicalTrials.gov record NCT01974206. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial to Evaluate the Efficacy and Safety of a Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seronegative Kidney Transplant Recipients Receiving an Organ From a CMV-Seropositive Donor
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study was to evaluate the efficacy of ASP0113 compared to placebo in reducing the incidence of cytomegalovirus (CMV) viremia in CMV-seronegative subjects receiving a kidney from a CMV-seropositive donor. This study also evaluated the safety of ASP0113 in this patient population.
Study identification
- NCT ID
- NCT01974206
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 150 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 20, 2013 (Actual)
- Primary completion
- May 13, 2016 (Actual)
- Completion
- Nov 5, 2020 (Actual)
- Last update posted
- Oct 24, 2024
2013 – 2020
United States locations
- U.S. sites
- 33
- U.S. states
- 24
- U.S. cities
- 29
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site US10026 | Phoenix | Arizona | 85054 | — |
| Site US10003 | Los Angeles | California | 90057 | — |
| Site US10004 | San Diego | California | 92123 | — |
| Site US10036 | San Francisco | California | 94115 | — |
| Site US10037 | San Francisco | California | 94143 | — |
| Site US10044 | Aurora | Colorado | 80045 | — |
| Site US10018 | New Haven | Connecticut | 06520 | — |
| Site US10058 | Atlanta | Georgia | 30309 | — |
| Site US10013 | Atlanta | Georgia | 30322 | — |
| Site US10030 | Chicago | Illinois | 60612 | — |
| Site US10009 | Chicago | Illinois | 60637 | — |
| Site US10057 | Indianapolis | Indiana | 46202 | — |
| Site US10046 | Lexington | Kentucky | 40536 | — |
| Site US10041 | New Orleans | Louisiana | 70121 | — |
| Site US10049 | Portland | Maine | 04102 | — |
| Site US10023 | Ann Arbor | Michigan | 48109-5364 | — |
| Site US10048 | Detroit | Michigan | 48202 | — |
| Site US10016 | St Louis | Missouri | 63110 | — |
| Site US10015 | Omaha | Nebraska | 68198 | — |
| Site US10045 | Buffalo | New York | 14215 | — |
| Site US10012 | The Bronx | New York | 10467 | — |
| Site US10050 | Greenville | North Carolina | 27858 | — |
| Site US10001 | Cleveland | Ohio | 44106 | — |
| Site US10042 | Pittsburgh | Pennsylvania | 15213 | — |
| Site US10047 | Charleston | South Carolina | 29425 | — |
| Site US10027 | Nashville | Tennessee | 37232 | — |
| Site US10028 | Houston | Texas | 77030 | — |
| Site US10014 | Salt Lake City | Utah | 84132 | — |
| Site US10038 | Charlottesville | Virginia | 22903 | — |
| Site US10031 | Richmond | Virginia | 23298 | — |
| Site US10020 | Seattle | Washington | 98101 | — |
| Site US10011 | Seattle | Washington | 98195-6175 | — |
| Site US10029 | Madison | Wisconsin | 53792 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 20 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01974206, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 24, 2024 · Synced Oct 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01974206 live on ClinicalTrials.gov.